NCT05364892Recruiting
Biocollection of Patients With ANCA Associated Vasculitis
Biocollection of Patients With ANCA Associated Vasculitis Diagnosed Within the CERAINO Autoimmune Disease Reference Center, Part of the Global BRAISE Project (B-dependent Rare AutoImmune DiseaSES
Source: ClinicalTrials.gov · Last updated 25 Jun 2026
Brief summary (registry, in English)
As rare disease, vasculitis affects a small number of patients, the cohorts available in the literature are few and the pathophysiological mechanisms remain to be elucidated. The collection of standardized data within a patientheque as part of a multi-year follow-up will facilitate the study of the characteristics of these diseases. This may, in particular, address the main objective of identifying predictors of relapse, as well as secondary objectives for predictive factors of mortality, infectious, cardiovascular or neoplastic complications that affect the prognosis of vasculitis in order to establish a more appropriate management of the patients concerned.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 21 Dec 2020
- Start date
- 27 Oct 2022
- Primary completion date
- 27 Oct 2032
- Lead sponsor
- University Hospital, Brest
- Diseases
- ANCA-associated vasculitis
- NCT number
- NCT05364892
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 27 Oct 2022 to the primary completion date, 27 Oct 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Hemoglobin (Hb) \< 7g/dL
Other
- Minor
- Patients unable to consent.
- Patients refusing to participate in research
- Patient under legal protection (tutelage, curatorship)
- Pregnant or lactating women
Who the study is looking for
- Major patients with no upper age limit.
- Patients assessed as part of the reference centre for rare autoimmune diseases at the CHRU in Brest.
- Patients for whom a diagnosis of ANCA-associated vasculitis is made by the physician in charge of the patient, according to the definitions of the Chapel-Hill Consensus Conference.
- Patient affiliated with Social Security
- Patient who has signed written informed consent
Age in the registry: 18 years to 99 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHRU de Brest - Service de rhumatologie Coordinator of this site? Confirm its status | Brest | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.